Evidence map›Paper›PMID 39036755›Full record

ArticleProstate international2024

Does androgenic alopecia aggravate the risk of prostate cancer? Evidence from Mendelian randomization.

Xianghua Shi, Yuan Pan, Jianhua Liu, Fei Luo, Binbin Li, Yuan Hu, Kai Chen

Abstract read
In one paragraph

Article in Prostate international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xianghua ShiDepartment of Urology, The First People's Hospital of Foshan, Foshan, Guangdong, 528000, China.
Yuan PanDepartment of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510280, China.
Jianhua LiuDepartment of Urology, The First People's Hospital of Foshan, Foshan, Guangdong, 528000, China.
Fei LuoDepartment of Urology, The First People's Hospital of Foshan, Foshan, Guangdong, 528000, China.
Binbin LiDepartment of Urology, The First People's Hospital of Foshan, Foshan, Guangdong, 528000, China.
Yuan HuDepartment of Urology, The First People's Hospital of Foshan, Foshan, Guangdong, 528000, China.
Kai ChenDepartment of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, 515031, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Epidemiological reports indicate a potential association between androgenic alopecia (AGA) and increased prostate cancer (PC) prevalence, but conflicting reports also exist. This study aims to elucidate the causality of AGA on PC risk using Mendelian randomization (MR) analysis. Materials and methods: Two-sample MR analyses utilized public genome-wide association studies summary data for single-nucleotide polymorphisms associated with AGA. Four statistical methods were used: inverse variance weighted (IVW), MR-Egger, weighted median, and weighted mode, with IVW as the preliminary estimation method. Additionally, sensitivity analyses were conducted to address pleiotropic bias. Results: Genetically proxied AGA did not demonstrate a causal effect on PC risk (IVW Conclusions: Our MR analysis indicates no causal relationship between genetically predicted AGA and PC risk, suggesting that observed associations in epidemiological studies may not be causal.

Indexed as

Androgenic alopeciaCausalityMendelian randomizationProstate cancer risk

Identifiers

PMID39036755
PMCPMC11255885

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.